MedPath

Investigating the effect of a soluble seaweed dietary fibre on wellness, gut flora and metabolism.

Phase 1
Conditions
Digestive health
Oxidative stress
Inflammatory status
glucose tolerance
Oral and Gastrointestinal - Normal oral and gastrointestinal development and function
Metabolic and Endocrine - Normal metabolism and endocrine development and function
Registration Number
ACTRN12615001057572
Lead Sponsor
niversity of Wollongong
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot yet recruiting
Sex
All
Target Recruitment
80
Inclusion Criteria

Overweight (BMI>24) individuals consuming an average western diet (as identified by K:Na ratio in 24hr urine and the initial record of 3 random 24hr dietary intakes). Presence of mild gut health concerns are allowed but not a requirement.

Exclusion Criteria

BMI<24
Concerning indications of very high blood pressure (as measured during recruitment or self diagnosed)
Very high glucose sensitivity
Medication of antibiotics (participants may finish with a shorter intervention if antibiotics are required)
Any other severe digestive conditions such as IBS or Chrons disease.
Coronary Heart Disease

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath